WELCEFO-CV DS is a paediatric combination providing cephalosporin antibacterial activity with beta-lactamase inhibition for selected susceptible infections. The suspension format offers convenient administration and dosing flexibility in children. A differentiated PCD Pharma Paediatric Antibiotic range product.
To provide additional activity against certain beta-lactamase-producing bacteria.
No.
Use strictly on prescription and complete the course. Confirm beta-lactam allergy and monitor for significant gastrointestinal or allergic reactions.
Diarrhea, nausea, vomiting, abdominal discomfort, headache and rash may occur.
WELCEFO-CV DS: Cefpodoxime inhibits bacterial cell-wall synthesis, while Clavulanic Acid inhibits susceptible beta-lactamases, helping preserve antibacterial activity.
